Literature DB >> 30352719

Use of Preventive Health Services Among Cancer Survivors in the U.S.

Soham Gupta1, Alexander P Cole1, Maya Marchese1, Ye Wang1, Jacqueline M Speed2, Sean A Fletcher1, Junaid Nabi1, Sebastian Berg1, Stuart R Lipsitz1, Toni K Choueiri3, Steven L Chang1, Adam S Kibel2, Annemarie Uhlig4, Quoc-Dien Trinh5.   

Abstract

INTRODUCTION: With improvements in early detection and treatment, a growing proportion of the population now lives with a personal history of a cancer. Although many cancer survivors are in excellent health, the underlying risk factors and side effects of cancer treatment increase the risk of medical complications and secondary malignancies.
METHODS: The 2013 National Health Interview Survey was utilized to assess the association between personal history of cancer and receipt of U.S. Preventive Services Task Force-recommended services, comprising three cancer screening tests (mammography, colonoscopy, and Pap smear) and six general medical preventive care services (aspirin for prevention of cardiovascular disease; blood pressure, cholesterol, and diabetes screening; diet/activity counseling; and tobacco use counseling). For each preventive service, patients with a history that would preclude that test were excluded. One to three matching of cancer survivors to controls was performed using propensity scores generated from patient-level demographic variables. Conditional logistic regression models were employed to compare odds of screening between matched cohorts of cancer survivors and controls. The years of analysis were 2015 and 2017.
RESULTS: A total of 2,639 cancer patients and 31,885 controls were extracted from the merged 2013 National Health Interview Survey. In the propensity score-matched cohorts of eligible adults, only one of the three cancer screening tests, colorectal, was more common in cancer survivors (OR=1.52, 95% CI=1.32, 1.75, p<0.001), whereas breast and cervical cancer screening were not more common in survivors. By contrast, all of the medical screening tests, with the exception of diabetes screening, were more common among cancer survivors.
CONCLUSIONS: The association between receipt of recommended preventive medical care and personal history of cancer varied, depending on the preventive service in question, but in the majority of preventive services assessed, cancer survivors had more frequent screening compared with non-cancer survivors.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30352719     DOI: 10.1016/j.amepre.2018.07.021

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  6 in total

1.  Colorectal Cancer Survivors' Receptivity toward Genomic Testing and Targeted Use of Non-Steroidal Anti-Inflammatory Drugs to Prevent Cancer Recurrence.

Authors:  Denalee M O'Malley; Cindy K Blair; Alissa Greenbaum; Charles L Wiggins; Ashwani Rajput; Vi K Chiu; Anita Y Kinney
Journal:  J Community Genet       Date:  2022-01-08

2.  Colonoscopy Insertion in Patients with Gastrectomy: Does Position Impact Cecal Intubation Time?

Authors:  Jae Hyun Kim; Youn Jung Choi; Hye Jung Kwon; Gyu Man Oh; Kyoungwon Jung; Sung Eun Kim; Won Moon; Moo In Park; Seun Ja Park
Journal:  Dig Dis Sci       Date:  2022-02-05       Impact factor: 3.487

3.  Disparities in colorectal cancer screening among breast and prostate cancer survivors.

Authors:  Chiranjeev Dash; Jiachen Lu; Vicky Parikh; Stacey Wathen; Samay Shah; Ruchi Shah Chaudhari; Lucile Adams-Campbell
Journal:  Cancer Med       Date:  2021-02-05       Impact factor: 4.711

4.  Cervical Cancer Screening Among Patients with Physical Disability.

Authors:  Lior Baruch; Avital Bilitzky-Kopit; Keren Rosen; Limor Adler
Journal:  J Womens Health (Larchmt)       Date:  2022-01-20       Impact factor: 3.017

5.  Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors.

Authors:  Meng-Han Tsai; Justin X Moore; Lorriane A Odhiambo; Sydney E Andrzejak; Martha S Tingen
Journal:  J Cancer Surviv       Date:  2022-10-10       Impact factor: 4.062

6.  Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors.

Authors:  Beth A Glenn; Narissa J Nonzee; Ann S Hamilton; Lina Tieu; Annette E Maxwell; Catherine M Crespi; L Cindy Chang; Dennis Deapen; Roshan Bastani
Journal:  J Cancer Surviv       Date:  2020-08-14       Impact factor: 4.442

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.